
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Not only did Shakespeare know a great deal about human nature, he knew something about brand equity: a name has value. Four hundred years later, marketers grapple to understand the association between brands and profitability.
about 25 years ago
Never Say “No Comment”





